This Article is From Nov 26, 2011

Glenmark Pharmaceuticals Ltd - Updates

Glenmark Pharmaceuticals Ltd - Updates
Glenmark Pharmaceuticals Ltd has informed BSE vide its letter dated June 27, 2011 that the GBR 500 deal signed by Glenmark in May'11 with Sanofi has received clearance from the Hart-Scott-Rodino Antitrust Improvements Act, USA. Following that clearance, the deal has now become effective and Glenmark has also received the first upfront payment of USD 25 million.